Comprehensive Analysis of Dystrophic Calcinosis Cutis in Systemic Sclerosis and Overlap Syndromes

on

 

Abstract— Dystrophic calcinosis cutis represents a debilitating manifestation of connective tissue diseases (CTDs), characterized by the ectopic deposition of calcium salts in cutaneous and subcutaneous tissues despite normal serum calcium and phosphate levels. This article examines a clinical case of a 42-year-old female diagnosed with an overlap syndrome involving limited systemic sclerosis and dermatomyositis, presenting with progressive, extensive calcinosis. We explore the pathophysiology, including the role of chronic inflammation and tissue damage, and provide a detailed review of imaging features, differential diagnosis, and contemporary multi-modal treatment strategies. The integration of radiographic imaging and clinical history is emphasized as the gold standard for diagnosis.

Keywords— Dystrophic Calcinosis Cutis, Systemic Sclerosis, Scleroderma, Dermatomyositis, Overlap Syndrome, Ectopic Calcification, Soft Tissue Imaging.

I. Introduction

Dystrophic calcinosis cutis (DCC) is the most common form of calcinosis cutis, occurring in the presence of normal mineral metabolism. It is frequently associated with systemic sclerosis (SSc) and dermatomyositis, where it serves as a marker of long-standing, often aggressive, underlying disease. The clinical impact ranges from localized discomfort to severe functional impairment, ulceration, and secondary infections.

II. Case Presentation and Imaging Analysis

A 42-year-old female presented with a history of an overlap syndrome comprising limited systemic sclerosis and dermatomyositis. Over time, she developed hard subcutaneous masses in her hips and elbows that progressed clinically and radiologically.

A. Radiographic Comparison

To appreciate the severity of DCC, one must compare pathological findings against normal anatomy.

Figure 1: Normal Pelvis A-P View. This image demonstrates a healthy pelvic structure with clear joint spaces, distinct cortical margins of the ilium and femur, and absence of soft tissue calcification.

 

Figure 2: Clinical Presentation of DCC. This photograph illustrates the presence of hard, yellowish-white nodules on the skin surface. These lesions are characteristic of calcium salt extrusion and localized inflammation.

 


Figure 3: Pathological Pelvis A-P View. This radiograph of the patient shows extensive, irregular radiopaque masses distributed throughout the soft tissues surrounding the pelvis and proximal femurs, diagnostic of advanced dystrophic calcinosis.

 

Figure 4: Coronal CT Scan. This cross-sectional imaging provides a detailed view of the depth and extent of the calcified deposits, showing dense, stone-like accumulations within the subcutaneous and muscular planes.

B. Involvement of Small Joints

While large joints like the hip are common sites, DCC frequently involves the hands, particularly in patients with SSc-related overlap syndromes or Sjögren’s syndrome.

 

Figure 5: Hand P-A Radiograph. This image shows significant calcinosis in a 63-year-old patient with RA and Sjögren’s syndrome. Note the massive, lobulated calcifications around the metacarpophalangeal and interphalangeal joints, leading to significant joint deformity.

III. Comprehensive Review of Dystrophic Calcinosis Cutis

A. Pathophysiology

DCC arises from localized tissue damage or chronic inflammation. Damage to the cellular structure leads to the release of alkaline phosphatase, which increases local phosphate levels, facilitating the precipitation of calcium phosphate or calcium carbonate salts. In CTDs like systemic sclerosis, microvascular hypoxia and repeated mechanical trauma further exacerbate the deposition process.

B. Epidemiology

DCC is found in approximately 25% to 40% of patients with limited systemic sclerosis (formerly CREST syndrome) and up to 30% of adults with dermatomyositis. It is more prevalent in patients with long-standing disease and those with specific autoantibodies, such as anti-centromere or anti-NXP2.

C. Clinical Presentation

  • Lesion Morphology: Firm, white-to-yellowish nodules or plaques.
  • Common Sites: Areas prone to trauma, such as fingers, elbows, knees, and hips.
  • Complications: Spontaneous discharge of "chalky" material, chronic ulceration, pain, and secondary bacterial infections.

D. Imaging Features

  • Plain Radiography: Highly sensitive; shows irregular, dense opacities in soft tissues.
  • CT: Optimal for assessing the 3D distribution and relationship to bone.
  • Ultrasound: Useful for identifying early, non-palpable deposits.

E. Differential Diagnosis

  1. Metastatic Calcinosis: Resulting from abnormal calcium/phosphate metabolism (e.g., renal failure).
  2. Tumoral Calcinosis: Often hereditary, involving massive periarticular deposits.
  3. Iatrogenic Calcinosis: Following intravenous calcium gluconate extravasation.
  4. Idiopathic Calcinosis: Occurring without underlying disease or metabolic imbalance.

F. Treatment

Treatment is notoriously difficult.

  • Medical: Calcium channel blockers (e.g., diltiazem), bisphosphonates, sodium thiosulfate (topical or IV), and minocycline.
  • Surgical: Excision for symptomatic or infected lesions, though recurrence is common.
  • Lifestyle: Cold protection and trauma avoidance to manage Raynaud’s and tissue stress.

G. Prognosis

The condition is chronic and often progressive. While not typically life-threatening, it severely impacts quality of life through pain and loss of mobility.

Quiz

Q1. A 42-year-old woman with systemic sclerosis presents with the radiograph seen in [Figure 3]. What is the most likely diagnosis for the dense soft tissue masses?

A) Osteosarcoma

B) Myositis ossificans

C) Dystrophic calcinosis cutis

D) Heterotopic ossification

E) Chondrosarcoma

  • Answer: C. Explanation: The patient’s history of systemic sclerosis and dermatomyositis, combined with normal serum levels and widespread soft tissue calcification, is pathognomonic for DCC.

Q2. Which of the following is a key pathophysiological mechanism in the development of Dystrophic Calcinosis Cutis?

A) Hyperparathyroidism

B) Excessive Vitamin D intake

C) Localized tissue damage and chronic inflammation

D) Malignant bone destruction

E) Elevated serum phosphorus

  • Answer: C. Explanation: Unlike metastatic calcinosis, DCC occurs in the presence of normal calcium/phosphate levels and is triggered by local tissue injury or inflammation.

Q3. Which systemic condition is frequently associated with the "chalky" skin nodules seen in the images?

A) Takayasu’s arteritis

B) Systemic sclerosis (Scleroderma)

C) Sarcoidosis

D) Familial hypertriglyceridemia

E) Type 2 Diabetes

  • Answer: B.  Explanation: Systemic sclerosis is a chronic autoimmune disease characterized by skin thickening and frequent calcinosis as part of its clinical spectrum.

References

[1] F. M. Wigley and A. Rosen, "Systemic Sclerosis (Scleroderma)," The New England Journal of Medicine, vol. 376, pp. 2400-2401, 2017.

[2] J. S. Walsh and L. Fairley, "Dystrophic Calcinosis Cutis," N. Engl. J. Med., vol. 367, no. 14, p. 1342, Oct. 2012. DOI: 10.1056/NEJMicm1211227.

[3] V. P. Werth, "Clinical manifestations of dermatomyositis," UpToDate, 2025.

[4] G. S. Robertson et al., "Dystrophic Calcinosis in the Hands of a Patient with Rheumatoid Arthritis and Secondary Sjögren’s Syndrome," Open Journal of Rheumatology and Autoimmune Diseases, vol. 3, no. 1, pp. 31-34, 2013. DOI: 10.4236/ojra.2013.31009.

[5] M. Baron et al., "Calcinosis in systemic sclerosis: A systematic review," Seminars in Arthritis and Rheumatism, 2024.

[6] C. P. Denton and D. Khanna, "Systemic sclerosis," The Lancet, vol. 390, no. 10103, pp. 1685-1699, 2017.

[7] R. G. Valenzuela et al., "Calcinosis in scleroderma," Current Opinion in Rheumatology, vol. 30, no. 6, pp. 554-561, 2018. 

Comments

Post a Comment